On exploring structure-activity relationships.
暂无分享,去创建一个
[1] Nina Nikolova-Jeliazkova,et al. QSAR Applicability Domain Estimation by Projection of the Training Set in Descriptor Space: A Review , 2005, Alternatives to laboratory animals : ATLA.
[2] Thomas Sander,et al. Toxicity-Indicating Structural Patterns , 2006, J. Chem. Inf. Model..
[3] J. Irwin,et al. ZINC ? A Free Database of Commercially Available Compounds for Virtual Screening. , 2005 .
[4] José L. Medina-Franco,et al. Consensus Models of Activity Landscapes with Multiple Chemical, Conformer, and Property Representations , 2011, J. Chem. Inf. Model..
[5] Lorenz C. Blum,et al. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. , 2009, Journal of the American Chemical Society.
[6] Shane Weaver,et al. The importance of the domain of applicability in QSAR modeling. , 2008, Journal of molecular graphics & modelling.
[7] Jürgen Bajorath,et al. Structural Interpretation of Activity Cliffs Revealed by Systematic Analysis of Structure-Activity Relationships in Analog Series , 2009, J. Chem. Inf. Model..
[8] Matthew Segall,et al. Beyond Profiling: Using ADMET Models to Guide Decisions , 2009, Chemistry & biodiversity.
[9] Mathias Wawer,et al. Elucidation of structure-activity relationship pathways in biological screening data. , 2009, Journal of medicinal chemistry.
[10] Dirk Schepmann,et al. Synthesis and SAR studies of chiral non-racemic dexoxadrol analogues as uncompetitive NMDA receptor antagonists. , 2010, Bioorganic & medicinal chemistry.
[11] Nathan Brown,et al. Exploiting QSAR methods in lead optimization. , 2006, Current opinion in drug discovery & development.
[12] H. Mewes,et al. Can we estimate the accuracy of ADME-Tox predictions? , 2006, Drug discovery today.
[13] Hua Gao,et al. Dimension related distance and its application in QSAR/QSPR model error estimation , 2003 .
[14] M. Natália D. S. Cordeiro,et al. Desirability‐based multiobjective optimization for global QSAR studies: Application to the design of novel NSAIDs with improved analgesic, antiinflammatory, and ulcerogenic profiles , 2008, J. Comput. Chem..
[15] Leo Breiman,et al. Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author) , 2001 .
[16] Jean-Louis Reymond,et al. Discovery of α7-Nicotinic Receptor Ligands by Virtual Screening of the Chemical Universe Database GDB-13 , 2011, J. Chem. Inf. Model..
[17] Forbes J. Burkowski,et al. A constructive approach for discovering new drug leads: Using a kernel methodology for the inverse-QSAR problem , 2009, J. Cheminformatics.
[18] David A. Winkler,et al. The role of quantitative structure-activity relationships (QSAR) in biomolecular discovery , 2002, Briefings Bioinform..
[19] W. Guida,et al. The art and practice of structure‐based drug design: A molecular modeling perspective , 1996, Medicinal research reviews.
[20] Rajarshi Guha,et al. Interpreting Computational Neural Network Quantitative Structure-Activity Relationship Models: A Detailed Interpretation of the Weights and Biases , 2005, J. Chem. Inf. Model..
[21] Paola Gramatica,et al. The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models , 2003 .
[22] Angelo Carotti,et al. Improving Quantitative Structure-Activity Relationships through Multiobjective Optimization , 2009, J. Chem. Inf. Model..
[23] Ajay N. Jain,et al. Does your model weigh the same as a Duck? , 2011, Journal of Computer-Aided Molecular Design.
[24] José L. Medina-Franco,et al. Characterization of Activity Landscapes Using 2D and 3D Similarity Methods: Consensus Activity Cliffs , 2009, J. Chem. Inf. Model..
[25] David T. Stanton,et al. On the Physical Interpretation of QSAR Models , 2003, J. Chem. Inf. Comput. Sci..
[26] Stefan Wetzel,et al. Interactive exploration of chemical space with Scaffold Hunter. , 2009, Nature chemical biology.
[27] Richard D. Cramer,et al. The inevitable QSAR renaissance , 2011, Journal of Computer-Aided Molecular Design.
[28] Rajarshi Guha,et al. Structure—Activity Landscape Index: Identifying and Quantifying Activity Cliffs. , 2008 .
[29] Gerald M. Maggiora,et al. On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..
[30] J. Bajorath,et al. SAR index: quantifying the nature of structure-activity relationships. , 2007, Journal of medicinal chemistry.
[31] Rajarshi Guha,et al. Development of QSAR Models To Predict and Interpret the Biological Activity of Artemisinin Analogues , 2004, J. Chem. Inf. Model..
[32] Jean-Loup Faulon,et al. The Signature Molecular Descriptor. 1. Using Extended Valence Sequences in QSAR and QSPR Studies , 2003, J. Chem. Inf. Comput. Sci..
[33] Rajarshi Guha,et al. On the interpretation and interpretability of quantitative structure–activity relationship models , 2008, J. Comput. Aided Mol. Des..
[34] Ivonne M C M Rietjens,et al. Promises and pitfalls of quantitative structure-activity relationship approaches for predicting metabolism and toxicity. , 2008, Chemical research in toxicology.
[35] Dimitris K. Agrafiotis,et al. Single R-Group Polymorphisms (SRPs) and R-Cliffs: An Intuitive Framework for Analyzing and Visualizing Activity Cliffs in a Single Analog Series , 2011, J. Chem. Inf. Model..
[36] M. Hewitt,et al. Assessing Applicability Domains of Toxicological QSARs: Definition, Confidence in Predicted Values, and the Role of Mechanisms of Action , 2007 .
[37] Tomasz Arodz,et al. Computational methods in developing quantitative structure-activity relationships (QSAR): a review. , 2006, Combinatorial chemistry & high throughput screening.
[38] John J. M. Wiener,et al. Scaffold explorer: an interactive tool for organizing and mining structure-activity data spanning multiple chemotypes. , 2010, Journal of medicinal chemistry.
[39] Bin Chen,et al. PubChem BioAssays as a data source for predictive models. , 2010, Journal of molecular graphics & modelling.
[40] Jean-Loup Faulon,et al. The signature molecular descriptor. 3. Inverse-quantitative structure-activity relationship of ICAM-1 inhibitory peptides. , 2003, Journal of molecular graphics & modelling.
[41] S. Chatterjee,et al. Influential Observations, High Leverage Points, and Outliers in Linear Regression , 1986 .
[42] T. Insel,et al. NIH Molecular Libraries Initiative , 2004, Science.
[43] Nina Nikolova-Jeliazkova,et al. An Approach to Determining Applicability Domains for QSAR Group Contribution Models: An Analysis of SRC KOWWIN , 2005, Alternatives to laboratory animals : ATLA.
[44] Robert P. Sheridan,et al. Similarity to Molecules in the Training Set Is a Good Discriminator for Prediction Accuracy in QSAR , 2004, J. Chem. Inf. Model..
[45] Boris Mirkin,et al. A Measure of Domain of Applicability for QSAR Modelling Based on Intelligent K-Means Clustering , 2007 .
[46] Valerie J Gillet,et al. Multiobjective optimization in quantitative structure-activity relationships: deriving accurate and interpretable QSARs. , 2002, Journal of medicinal chemistry.
[47] Igor V Tetko,et al. A comparison of different QSAR approaches to modeling CYP450 1A2 inhibition , 2011, J. Chem. Inf. Model..
[48] Paola Gramatica,et al. Statistically Validated QSARs, Based on Theoretical Descriptors, for Modeling Aquatic Toxicity of Organic Chemicals in Pimephales promelas (Fathead Minnow) , 2005, J. Chem. Inf. Model..
[49] Leo Breiman,et al. Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author) , 2001, Statistical Science.
[50] Matthias Rarey,et al. Cover Picture: From Activity Cliffs to Target‐Specific Scoring Models and Pharmacophore Hypotheses (ChemMedChem 9/2011) , 2011 .
[51] J. Bajorath,et al. Structure-activity relationship anatomy by network-like similarity graphs and local structure-activity relationship indices. , 2008, Journal of medicinal chemistry.
[52] Petra S Kern,et al. Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization. , 2007, Chemical research in toxicology.
[53] Bo-Han Su,et al. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets. , 2011, Chemical research in toxicology.